The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
Open accessAbstract
Heat-shock factor 1 (HSF1) is the master transcriptional regulator of the cellular response to heat and a wide variety of other stressors. We previously reported that HSF1 promotes the survival and proliferation of malignant cells. At this time, however, the clinical and prognostic significance of HSF1 in cancer is unknown. To address this issue breast cancer samples from 1,841 participants in the Nurses’ Health Study were scored for levels of nuclear HSF1. Associations of HSF1 status with clinical parameters and survival outcomes were investigated by Kaplan–Meier analysis and Cox proportional hazard models. The associations were further delineated by Kaplan–Meier analysis using publicly available mRNA expression data. Our results show that nuclear HSF1 levels were elevated in ∼80% of in situ and invasive breast carcinomas. In invasive carcinomas, HSF1 expression was associated with high histologic grade, larger tumor size, and nodal involvement at diagnosis ( P < 0.0001). By using multivariate analysis to account for the effects of covariates, high HSF1 levels were found to be independently associated with increased mortality (hazards ratio: 1.62; 95% confidence interval: 1.21–2.17; P < 0.0013). This association was seen in the estrogen receptor (ER)-positive population (hazards ratio: 2.10; 95% confidence interval: 1.45–3.03; P < 0.0001). In public expression profiling data, high HSF1 mRNA levels were also associated with an increase in ER-positive breast cancer-specific mortality. We conclude that increased HSF1 is associated with reduced breast cancer survival. The findings indicate that HSF1 should be evaluated prospectively as an independent prognostic indicator in ER-positive breast cancer. HSF1 may ultimately be a useful therapeutic target in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Self-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Self-citationHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 1×
“In yeast, HSP90, an important regulatory target of HSF1, potentiates the emergence of drug resistance by enabling the generation of greater phenotypic diversity (22).”
BackgroundSelf-citationAneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells
Williams, B. R., Prabhu, V. R., Hunter, K. E., Glazier, C. M., Whittaker, C. A., Housman, D. E., & Amon, A. (2008) · Science · doi:10.1126/science.1160058 · Cited by 666
Xiao, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5943 · Cited by 550
Molecular cloning and expression of a human heat shock factor, HSF1.
Rabindran, S. K., Giorgi, G., Clos, J., & Wu, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6906 · Cited by 467
Modi, S., Stopeck, A., Linden, H., Solit, D., Chandarlapaty, S., Rosen, N., D'Andrea, G., Dickler, M., Moynahan, M. E., Sugarman, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0072 · Cited by 424
Isolation of the gene encoding the S. cerevisiae heat shock transcription factor
Wiederrecht, G., Seto, D., & Parker, C. S. (1988) · Cell · doi:10.1016/s0092-8674(88)91197-x · Cited by 408
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Hu, R., Dawood, S., Holmes, M. D., Collins, L. C., Schnitt, S. J., Cole, K., Marotti, J. D., Hankinson, S. E., Colditz, G. A., & Tamimi, R. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2021 · Cited by 396
Self-citationNon-Oncogene Addiction and the Stress Phenotype of Cancer Cells
Solimini, N. L., Luo, J., & Elledge, S. J. (2007) · Cell · doi:10.1016/j.cell.2007.09.007 · Cited by 365
Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer
Tamimi, R. M., Baer, H. J., Marotti, J., Galan, M., Galaburda, L., Fu, Y., Deitz, A. C., Connolly, J. L., Schnitt, S. J., Colditz, G. A., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2128 · Cited by 343
Self-citationModi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7960 · Cited by 335
Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309
Self-citationZhao, Y. H., Zhou, M., Liu, H., Ding, Y., Khong, H. T., Yu, D., Fodstad, O., & Tan, M. (2009) · Oncogene · doi:10.1038/onc.2009.229 · Cited by 269
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
Kumar, R., Wang, R.-A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., Bagheri-Yarmand, R., Sahin, A., Hortobagyi, G., Adam, L., et al. (2002) · Nature · doi:10.1038/nature00889 · Cited by 242
Chromatin Landscape Dictates HSF Binding to Target DNA Elements
Guertin, M. J., & Lis, J. T. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001114 · Cited by 226
Inhibiting the transcription factor HSF1 as an anticancer strategy
Whitesell, L., & Lindquist, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902832697 · Cited by 222
Self-citationThe Origins and Implications of Intratumor Heterogeneity
Michor, F., & Polyak, K. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0234 · Cited by 209
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Whitesell, L., Bagatell, R., & Falsey, R. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481787 · Cited by 203
Self-citationMerlo, L. M. F., Shah, N. A., Li, X., Blount, P. L., Vaughan, T. L., Reid, B. J., & Maley, C. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0108 · Cited by 164
Min, J.-N., Huang, L., Zimonjic, D. B., Moskophidis, D., & Mivechi, N. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210317 · Cited by 162
Hoang, A. T., Huang, J., Rudra-Ganguly, N., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64954-1 · Cited by 150
Le, M., Gabai, V. L., & Sherman, M. Y. (2010) · Oncogene · doi:10.1038/onc.2010.277 · Cited by 147
Page, T. J., Sikder, D. S., Yang, L., Pluta, L., Wolfinger, R. D., Kodadek, T. J., & Thomas, R. S. (2006) · Molecular BioSystems · doi:10.1039/b606129j · Cited by 145
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes
Scott, K. L., Nogueira, C., Heffernan, T. P., van Doorn, R., Dhakal, S., Hanna, J. A., Min, C., Jaskelioff, M., Xiao, Y., Wu, C., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.025 · Cited by 144
Khaleque, A., Bharti, A. K., Sawyer, D. B., Gong, J., Benjamin, I. J., Stevenson, M. A., & Calderwood, S. K. (2005) · Oncogene · doi:10.1038/sj.onc.1208798 · Cited by 115
MTA family of coregulators in nuclear receptor biology and pathology
Manavathi, B., Singh, K., & Kumar, R. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05010 · Cited by 108
Heat shock proteins in breast cancer progression–A suitable case for treatment?
Calderwood, S. K. (2010) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.490254 · Cited by 90
Ramanathan, R. K., Egorin, M. J., Erlichman, C., Remick, S. C., Ramalingam, S. S., Naret, C., Holleran, J. L., TenEyck, C. J., Ivy, S. P., & Belani, C. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0415 · Cited by 89
Riluzole Increases the Amount of Latent HSF1 for an Amplified Heat Shock Response and Cytoprotection
Yang, J., Bridges, K., Chen, K. Y., & Liu, A. Y. ‐. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002864 · Cited by 65
Negative Regulation of Estrogen Receptor α Transactivation Functions by LIM Domain Only 4 Protein
Singh, R. R., Barnes, C. J., Talukder, A. H., Fuqua, S. A. W., & Kumar, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2268 · Cited by 64
Translation initiation: a critical signalling node in cancer
Robert, F., & Pelletier, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241625 · Cited by 54
The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target
Barginear, M. F., Poznak, C. H. V., Rosen, N. X., Modi, S., Hudis, C. A., & Budman, D. R. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785699379 · Cited by 49
de Billy, E., Powers, M. V., Smith, J. R., & Workman, P. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10423 · Cited by 37
Treatment of HER2-Positive Metastatic Breast Cancer Following Initial Progression
Mayer, I. A. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.s.005 · Cited by 28
Cited by
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
Mendillo, M. L., Santagata, S., Koeva, M., Bell, G. W., Hu, R., Tamimi, R. M., Fraenkel, E., Ince, T. A., Whitesell, L., & Lindquist, S. (2012) · Cell · doi:10.1016/j.cell.2012.06.031 · Cited by 694
Self-citationOrigin, Methods, and Evolution of the Three Nurses’ Health Studies
Bao, Y., Bertoia, M. L., Lenart, E. B., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Chavarro, J. E. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303338 · Cited by 556
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Chatterjee, S., & Burns, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091978 · Cited by 501
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Scherz-Shouval, R., Santagata, S., Mendillo, M. L., Sholl, L. M., Ben-Aharon, I., Beck, A. H., Dias-Santagata, D., Koeva, M., Stemmer, S. M., Whitesell, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.045 · Cited by 386
Self-citation
Metadata
- Authors
- Santagata, S., Hu, R., Lin, N. U., Mendillo, M. L., Collins, L. C., Hankinson, S. E., Schnitt, S. J., Whitesell, L., Tamimi, R. M., Lindquist, S., & Ince, T. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-10-31
- Volume
- 108
- Issue
- 45
- Pages
- 18378-18383
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2121565438
- Cited by
- 311
- References
- 40
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.